Sygnature Discovery launches in vivo inflammation model and includes kidney and neuroinflammation 12-Jun-2023 By Liza Laws Sygnature Discovery has launched an in vivo inflammation model, that the company says is ‘exciting but only the beginning’ of understanding life-limiting neuroinflammatory conditions.